SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SIBIA Neurosciences (SIBI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Czechsinthemail who wrote (58)8/13/1997 12:39:00 AM
From: scaram(o)uche   of 579
 
Does sound a bit better than I expected. "Optimistic" and "near-term". That makes two from the Ciba program (one each, epilepsy and stroke), one from the BMY program, one from the "53 series", and a Lilly selection that they are optimistic about, near-term. Add 1508Y. Either Dr. Comer et al. are overly optimistic, or the place is going to be hopping.

Again, at the annual meeting, they talked about migraine/VGCC, pulled back at the last Lilly renewal.

Thanks, Baird.

Rick
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News